First province in Canada to publicly reimburse this expanded indication of Jemperli, marking a significant milestone in access to treatment. This listing removes a key financial barrier for eligible Quebecers, enabling… Read More
Understanding how immune cells recognize one another is essential for developing better treatments for cancer, autoimmune disease, and inflammation. Many of the signals they use involve glycans, the complex sugars… Read More
This achievement exemplifies Phyton’s broad fermentation capabilities across organism classes Ahrensburg, DE – Phyton Biotech has successfully transferred the manufacturing process for the microbial production of Corallopyronin A (CorA). CorA… Read More
New UBC research shows that a B.C.-developed surgical procedure dramatically reduces rates of the most lethal gynaecological cancer. A prevention strategy developed by B.C. researchers reduces the risk of the… Read More
First ever head-to-head analysis compares overall survival outcomes of ERLEADA® versus darolutamide Retrospective study reinforces real-world efficacy of ERLEADA® for patients with mCSPC HORSHAM, PA – Johnson & Johnson announced new real… Read More
